New project will use next-gen at-home rapid test to track COVID-19, RSV, and flu

CUNY ISPH to launch next phase of community-based cohort study to track short- and long-term effects of multiple respiratory viruses

2024-03-04

(Press-News.org) The City University of New York (CUNY) Institute for Implementation Science in Population Health (ISPH) and the CUNY Graduate School of Public Health and Health Policy (CUNY SPH), in collaboration with Pfizer, are initiating a critical two-year prospective epidemiologic study in the spring of 2024 to track acute respiratory infections across the United States.

Project PROTECTS (Prospective Respiratory Outcomes from Tracking and Evaluating Community-based TeSting) builds on the pivotal CHASING COVID Cohort Study, which has monitored SARS-CoV-2 infection rates and associated risk factors through questionnaires and at-home serological testing since March 2020. The cohort's participants have shown remarkable commitment, with the study recently concluding its 22nd questionnaire and fourth round of serological testing. “The sustained engagement of CHASING COVID Cohort Study participants has made the cohort one of the most enduring and thorough community-based studies of the SARS-CoV-2 pandemic, and represents an invaluable resource for ongoing scientific inquiry,” says CUNY SPH Distinguished Professor of Epidemiology Denis Nash, who is also the principal investigator of the study.

This new project will harness both at-home rapid and PCR tests to investigate the incidence and symptom severity of several major respiratory viruses (SARS-CoV-2, RSV, influenza A, and influenza B), and characterize the performance of a new at-home multi-pathogen rapid test. “The study will address significant gaps in our understanding of the prolonged effects of these viruses on daily life, in the context of existing vaccines, background immunity, and treatments,” says Nash. The study will use a single rapid test for four different viruses that is currently in the research pipeline and not yet available to providers or patients.

To achieve study aims, Project PROTECTS aims to enroll up to 6,000 participants, starting with individuals who were engaged in the CHASING COVID cohort. Participants will complete quarterly questionnaires on existing symptoms, health status, quality of life, occupational activities, vaccination history, past respiratory illnesses, and healthcare utilization using a study-specific web platform and mobile app.

When participants exhibit symptoms of an acute respiratory infection, they will self-administer the multi-pathogen rapid test designed to test for all four respiratory viruses. It is administered in the same way as at-home SARS-CoV-2 tests. However, it simultaneously tests for SARS-CoV-2, RSV, influenza A, and influenza B, and can also detect co-infections. Those who test positive for one or more pathogens will complete questionnaires over the ensuing six months, with additional measures detailing symptoms, healthcare engagements and treatments, and new clinical diagnoses.

“The findings are expected to be pivotal in shaping future public health strategies and interventions to mitigate the impact of severe respiratory viruses on population health outcomes,” says Nash.

About the CUNY ISPH
The CUNY Institute for Implementation Science in Population Health (ISPH) was founded on the notion that substantial improvements in population health can be efficiently achieved through better implementation of existing strategies, policies, and interventions across multiple sectors. With that in mind, we study how to translate and scale up evidence-based interventions and policies within clinical and community settings in order to improve population health and reduce health disparities. cunyisph.org

About the CUNY SPH
The CUNY Graduate School of Public Health and Health Policy (CUNY SPH) is committed to promoting and sustaining healthier populations in New York City and around the world through excellence in education, research, and service in public health and by advocating for sound policy and practice to advance social justice and improve health outcomes for all. sph.cuny.edu

END

ELSE PRESS RELEASES FROM THIS DATE:

SRI relaunches the PARC Forum event series as it celebrates the first anniversary of acquiring the storied Palo Alto Research Center

2024-03-04

Menlo Park, CA: SRI announced today the relaunch of PARC Forum, an event and program series that brings together some of the world’s leading thinkers for thought-provoking conversations at the intersection of technology and society. The first PARC Forum event marks the first anniversary of SRI’s acquisition through a donation from Xerox of the Palo Alto Research Center (PARC ). The acquisition brought together two iconic Silicon Valley organizations that have created and delivered technologies, services, and ideas that have had a profound impact on every one of our lives. SRI’s ...

An inside look at Beech tree disease

2024-03-04

Beech trees provide food for animals, timber for wood products, and sustenance for beech drop plants, but they are under threat from Beech Leaf Disease (BLD). The disease, first documented in 2012 in the Midwest, is associated with the nematode Litylenchus crenatae mccannii and is spreading rapidly throughout the central and northeast regions of North America. A team of scientists led by Craig Brodersen, professor of plant physiological ecology, and Leila Fletcher, postdoctoral associate, at the Yale School of the Environment has uncovered ...

New AI model draws treasure maps to diagnose disease

2024-03-04

Medical diagnostics expert, doctor’s assistant, and cartographer are all fair titles for an artificial intelligence model developed by researchers at the Beckman Institute for Advanced Science and Technology. Their new model accurately identifies tumors and diseases in medical images and is programmed to explain each diagnosis with a visual map. The tool’s unique transparency allows doctors to easily follow its line of reasoning, double-check for accuracy, and explain the results to patients. "The idea is to help catch cancer and disease in its earliest stages — like an X on ...

Breastfeeding after COVID-19 booster can give babies antibodies

2024-03-04

Lactating mothers who get the COVID-19 booster pass along the antibodies to their children via their breast milk – and potentially protect babies too young to receive the vaccine, a study from the University of Florida Institute of Food and Agricultural Sciences (UF/IFAS) and the UF College of Medicine found. The study is the third in a series that looks at antibody protection being transferred via breast milk from mothers who received their first two COVID-19 vaccinations and, now, the booster shot. The second publication reported the same antibody transfer via breast milk. “We think that breast milk may play an important ...

Researchers closing in on genetic treatments for hereditary lung disease, vision loss

2024-03-04

PORTLAND, Ore. – Researchers who work with tiny drug carriers known as lipid nanoparticles have developed a new type of material capable of reaching the lungs and the eyes, an important step toward genetic therapy for hereditary conditions like cystic fibrosis and inherited vision loss. Findings of the study led by Gaurav Sahay and Yulia Eygeris of the Oregon State University College of Pharmacy and Renee Ryals of Oregon Health & Science University were published today in the Proceedings of the National Academy of Sciences. Unlike other types of lipid nanoparticles that tend to accumulate in the liver, the ones in this study, ...

COVID-19 associated with increased risk for autoimmune inflammatory rheumatic diseases up to a year after infection

2024-03-04

Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization they represent.   ----------------------------   1. COVID-19 associated with increased risk for autoimmune inflammatory rheumatic diseases up to a year after infection Vaccination showed some protection against AIRDs, depending on severity ...

UC Irvine receives $15 million NSF grant for integrative movement research

2024-03-04

Irvine, Calif. March 4, 2024 — The National Science Foundation has granted $15 million to the Integrative Movement Sciences Institute at the University of California, Irvine. This six-year funding, part of the NSF’s Biology Integration Institutes program, will support groundbreaking research led by Monica Daley, professor of ecology & evolutionary biology at the UCI School of Biological Sciences. The research funded by this grant aims to understand the intricate mechanics of muscle control during rapid, unsteady movements in complex environments. Muscle ...

University of Houston engineer Metin Akay featured in study highlighting 50 scientists' contributions to biomedical engineering advancements

2024-03-04

Metin Akay, founding chair of the Biomedical Engineering Department at the University of Houston and John S. Dunn Professor, is one of 50 top scientists from 34 elite universities to publish a roadmap for groundbreaking research to transform the landscape of medicine in the coming decade. Published on behalf of the Institute of Electrical and Electronics Engineers (IEEE), the world’s largest technical professional organization dedicated to advancing technology for humanity and the IEEE Engineering in Medicine and Biology Society (IEEE EMBS), the paper focus ...

JWST captures the end of planet formation

2024-03-04

March 4, 2024, Mountain View, CA – The James Webb Space Telescope (JWST) is helping scientists uncover how planets form by advancing understanding of their birthplaces and the circumstellar disks surrounding young stars, in a paper published in the Astronomical Journal, a team of scientists led by Naman Bajaj of the University of Arizona and including Dr. Uma Gorti at the SETI Institute, image for the first time, winds from an old planet-forming disk (still very young relative to the Sun) which is actively dispersing its gas ...

Good news—MS drugs taken while breastfeeding may not affect child development

2024-03-04

EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, MONDAY, MARCH 4, 2024 MINNEAPOLIS – Certain medications for multiple sclerosis (MS) called monoclonal antibodies, taken while breastfeeding, may not affect the development of a child during the first three years of life, according to a preliminary study released today, March 4, 2024. The study will be presented at the American Academy of Neurology’s 76th Annual Meeting taking place April 13–18, 2024, in person in Denver and online. The study examined four monoclonal antibodies for MS: natalizumab, ocrelizumab, rituximab and ofatumumab. MS is a disease in which the body’s immune system attacks ...

New project will use next-gen at-home rapid test to track COVID-19, RSV, and flu

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: